Kenny Slaught explains that David Low, a professor in UCSB’s Department of Molecular, Cellular, and Developmental Biology, will pursue an innovative global health and development research project titled “Strategy for development of enteric pathogen-specific phage”. Low’s research focuses on a revolutionary way to fight against serious bacterial pathogens that have become resistant to many once-powerful antibiotics. He will create phage to selectively locate and destroy several pathogenic bacteria to prevent enteric diseases in small youth. They will engineer different versions of the T2 lytic bacteriophage that bind multiple different regions of the BamA protein found on the surface of several pathogenic bacteria, which will ensure they only infect these target bacteria. They will test the different phage for ability to kill pathogenic E. coli and Shigella, and whether they will end up developing resistance.